Cargando…
Risk Factors of Very Severe RSV Infections in a Multicenter Cohort of Very Preterm and Extreme Preterm Babies Receiving or Not Palivizumab
INTRODUCTION: Preterm infants are at risk of lower respiratory tract infections (LRTI), including Respiratory Syncytial Virus (RSV) associated bronchiolitis, for which palivizumab prophylaxis can be proposed. Our aim was to determine risk factors of very severe RSV disease in children born before 34...
Autores principales: | Mulot, Gwenaelle, Benchaib, Mehdi, Plaisant, Frank, Ploin, Dominique, Gillet, Yves, Javouhey, Etienne, Claris, Olivier, Picaud, Jean-Charles, Casalegno, Jean-Sebastien, Butin, Marine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301069/ https://www.ncbi.nlm.nih.gov/pubmed/35874569 http://dx.doi.org/10.3389/fped.2022.884120 |
Ejemplares similares
-
Identifying the Target Population for Primary Respiratory Syncytial Virus Two-Step Prevention in Infants: Normative Outcome of Hospitalisation Assessment for Newborns (NOHAN)
por: Jourdain, Marine, et al.
Publicado: (2022) -
RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020
por: Packnett, Elizabeth R., et al.
Publicado: (2022) -
Level of maternal antibodies against respiratory syncytial virus (RSV) nucleoprotein at birth and risk of RSV very severe lower respiratory tract infection
por: Receveur, Matthieu, et al.
Publicado: (2022) -
Application of a forecasting model to mitigate the consequences of unexpected RSV surge: Experience from the post-COVID-19 2021/22 winter season in a major metropolitan centre, Lyon, France
por: Casalegno, Jean-Sebastien, et al.
Publicado: (2023) -
Estimating neonatal length of stay for babies born very preterm
por: Seaton, Sarah E, et al.
Publicado: (2019)